Neutropenia
📧 Sign up to get email alerts when something new happens for Neutropenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-15Clinical Trial Update: Sequential Cadaveric Lung and Bone Marrow Transplant for Immune Deficiency Diseases [Phase 1, Phase 2]
This clinical trial update describes an early-phase study evaluating sequential cadaveric lung transplantation followed by bone marrow trans…
-
CLINICAL_TRIALS trial_result · 2025-12-11Clinical Trial Update: DIStinguishing ChildrEn at Low Risk of Severe infectioN in Case of Febrile Neutropenia-7: Impact Study of a Clinical Decision Rule [NA]
Trial update noting the termination status of the DIStinguishing Children at Low Risk of Severe infection in Case of Febrile Neutropenia-7 t…
-
CLINICAL_TRIALS trial_result · 2025-11-06Clinical Trial Update: PC001- A Study to Evaluate the Usability of PointCheck [NA]
The PC001 usability study for PointCheck conducted by Leuko Labs has completed.
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: Hepatosplenic CANdidiasis : PETscan and Immune Response Analysis [NA]
A completed clinical trial evaluating hepatosplenic candidiasis using PET scans and immune response analysis in patients with invasive candi…
-
CLINICAL_TRIALS trial_result · 2025-04-20Clinical Trial Update: Study to Compare the Efficacy and Safety of F-627 and GRAN® [Phase 3]
Phase 3 trial comparing F-627 with GRAN® in breast cancer; the study is completed and results have been posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-04-09Clinical Trial Update: Early Termination of Empirical Antibiotics in Febrile Neutropenia in Children With Cancer [NA]
This clinical trial evaluating early cessation of empiric antibiotics in pediatric cancer patients with febrile neutropenia was completed.
-
CLINICAL_TRIALS trial_result · 2024-08-16Clinical Trial Update: Biosimilarity Study of Subcutaneous Pegfilgrastim in Healthy Volunteers [Phase 1]
Phase 1 biosimilarity study evaluating subcutaneous pegfilgrastim in healthy volunteers to assess pharmacokinetic/pharmacodynamic similarity…
-
CLINICAL_TRIALS trial_result · 2024-08-12Clinical Trial Update: Antibiotics Management of Septic Neutropenic Patients in the Intensive Care Unit
Clinical trial update indicating that the study on antibiotics management for septic neutropenic patients in the Intensive Care Unit has com…
-
CLINICAL_TRIALS trial_result · 2024-03-19Clinical Trial Update: Reduced Dose of Pegfilgrastim as Support for Chemotherapy for Breast Cancer [Phase 3]
Phase 3 trial assessing reduced-dose pegfilgrastim as support for chemotherapy in breast cancer.
-
CLINICAL_TRIALS trial_result · 2024-02-23Clinical Trial Update: Study of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy [Phase 1]
Phase 1 trial of F-627 in women with breast cancer receiving myelotoxic chemotherapy has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-12-27Clinical Trial Update: Colony-Stimulating Factors to Relieve Neutropenia in Patients With Recurrent Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial updating the use of colony-stimulating factors to relieve neutropenia in patients with recurrent non-Hodgkin's lymphoma.
-
CLINICAL_TRIALS trial_result · 2023-01-05Clinical Trial Update: Umbilical Cord Derived Mesenchymal Stem Cells for Treatment-induced Myelosuppression in Hematologic Malignancies [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating umbilical cord–derived mesenchymal stem cells for treatment-induced myelosuppression in hematologic mali…
-
CLINICAL_TRIALS trial_result · 2022-04-15Clinical Trial Update: Phase 2 Study of SPI-2012 or Pegfilgrastim for the Management of Neutropenia in Participants With Breast Cancer [Phase 2]
Phase 2 study of SPI-2012 or Pegfilgrastim for managing neutropenia in breast cancer has completed; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-03-02Clinical Trial Update: SPI-2012 vs Pegfilgrastim in Management of Neutropenia in Breast Cancer Participants With Docetaxel and Cyclophosphamide [Phase 3]
Phase 3 trial comparing SPI-2012 to Pegfilgrastim for neutropenia management in breast cancer patients receiving docetaxel and cyclophospham…
-
CLINICAL_TRIALS trial_result · 2021-11-05Clinical Trial Update: A Study of Amphotericin B Liposome for Injection in Patients With Persistent Neutropenia and Fever [Phase 3]
Phase 3 clinical trial update for amphotericin B liposome in patients with persistent neutropenia and fever.
-
CLINICAL_TRIALS trial_result · 2021-05-07Clinical Trial Update: Neulasta-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy [Phase 3]
Phase 3 trial evaluating F-627 (Neulasta-controlled) in women with breast cancer undergoing myelotoxic chemotherapy has completed and posted…
-
CLINICAL_TRIALS trial_result · 2020-11-02Clinical Trial Update: Low-risk Fever and Neutropenia in Children With Cancer: Safety and Efficacy of Oral Antibiotics in an Outpatient Setting [Phase 3]
Phase 3 trial evaluating safety and efficacy of oral antibiotics for low-risk fever and neutropenia in outpatient children with cancer; stud…
-
CLINICAL_TRIALS trial_result · 2020-10-28Clinical Trial Update: Efficacy and Safety of 4.5mg PEG-rhG-CSF Per Cycle in Preventing Neutropenia After Intensive Chemotherapy for Breast Cancer [Phase 4]
Phase 4 trial assessing the efficacy and safety of 4.5 mg PEG-rhG-CSF per cycle to prevent neutropenia after intensive chemotherapy in breas…
-
CLINICAL_TRIALS trial_result · 2020-09-24Clinical Trial Update: LIFEMEL Efficacy in Preventing Haematopoietic Toxicity in Patients Treated With Chemotherapy [Phase 2]
A Phase 2 clinical trial update reports on the efficacy of LIFEMEL in preventing hematopoietic toxicity (neutropenia) in patients undergoing…
-
CLINICAL_TRIALS trial_result · 2019-12-23Clinical Trial Update: Home Away From Home - Medical Outcomes
Completed clinical trial update for a study involving acute myeloid leukemia and neutropenia with mention of bacteremia results.
-
CLINICAL_TRIALS trial_result · 2019-12-06Clinical Trial Update: Cefepime vs Ceftazidime as Empirical Therapy for Neutropenic Fever [Phase 4]
A Phase 4 clinical trial comparing cefepime to ceftazidime as empirical therapy for neutropenic fever has completed.
-
CLINICAL_TRIALS trial_result · 2019-11-21Clinical Trial Update: A Pharmacokinetics/Dynamics Ib Study of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy [Phase 1, Phase 2]
Phase 1/2 pharmacokinetics/dynamics study of F-627 in women with neutropenia undergoing myelotoxic chemotherapy has completed.
-
CLINICAL_TRIALS trial_result · 2019-07-26Clinical Trial Update: Safety and Pharmacokinetics of Intravenous and Oral Posaconazole in Immunocompromised Children (MK-5592-097) [Phase 1]
Phase 1 study evaluating safety and pharmacokinetics of intravenous and oral posaconazole in immunocompromised children with neutropenia.
-
CLINICAL_TRIALS trial_result · 2019-03-26Clinical Trial Update: Placebo-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy [Phase 3]
Phase 3 trial update for F-627 in women with breast cancer undergoing myelotoxic chemotherapy; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-10-26Clinical Trial Update: Bioavailability Study of Lozanoc™ 65 mg Itraconazole Capsules in Patients Requiring Prophylaxis [Phase 2]
Phase 2 trial evaluating the bioavailability of Lozanoc 65 mg itraconazole capsules for prophylaxis in neutropenia patients has been complet…